What is the prevalence of Dysplasia Epiphysealis Hemimelica / Trevor Disease?
How many people does Dysplasia Epiphysealis Hemimelica / Trevor Disease affect? Does it have the same prevalence in men and women? And in the different countries?
Dysplasia Epiphysealis Hemimelica, also known as Trevor Disease, is a rare developmental bone disorder that affects the growth plates in children. The prevalence of this condition is extremely low, with only a few hundred cases reported worldwide. It typically presents unilaterally in the lower extremities, causing abnormal bone growth and deformities. The exact cause of Dysplasia Epiphysealis Hemimelica is unknown, and there is no known cure. Treatment options focus on managing symptoms and may include surgical interventions to correct skeletal abnormalities. Early diagnosis and intervention are crucial for optimizing outcomes in affected individuals.
Dysplasia Epiphysealis Hemimelica (DEH), also known as Trevor Disease, is a rare developmental bone disorder that primarily affects children and adolescents. It is characterized by an overgrowth of cartilage within the epiphysis, or the end part of a long bone, leading to deformities and functional impairments.
The prevalence of DEH is extremely low, with only a few hundred cases reported in medical literature. It is estimated to occur in approximately 1 in every 1 million individuals, making it an exceptionally rare condition.
DEH typically presents unilaterally, affecting only one side of the body, and commonly involves the lower extremities such as the knee or ankle. The exact cause of DEH remains unknown, and it is not believed to be hereditary.
Early diagnosis and intervention are crucial in managing DEH. Treatment options may include surgical interventions to correct deformities, relieve pain, and improve joint function. Regular monitoring and follow-up care are necessary to address potential complications and ensure optimal outcomes.
